These lab-made options weren't developed with recreational use in mind. Within the nineties, John W. Huffman and also a crew of fellow chemists at Clemson University developed a number of the very first formulation for synthetic cannabinoid receptor agonists (SCRAs), a family members of substances that imitate the physiological and psychological im